Stock Taper
AdaptHealth Corp. provides home medical equipment, supplies, and services—including sleep therapy, diabetes devices, oxygen, and chronic care solutions—to patients across the U.S., serving Medicare, Medicaid, and commercial insurance beneficiaries.

The Dexcom G7 is a wearable, real-time glucose sensor integrated into AdaptHealth's portfolio, offering advanced, connected-care solutions for diabetes management without fingersticks.
| Icon | PRODUCT | Q2-2025 | Q3-2025 | Q4-2025 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Respiratory Health | $170.45M | $177M ▲ | $178.23M ▲ | $194.4M ▲ |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
UFPT | $300.05 | COMPARE |
ESTA | $70.64 | COMPARE |
HCSG | $22.44 | COMPARE |
CNMD | $49.98 | COMPARE |
IRMD | $87.07 | COMPARE |
STAA | $22.11 | COMPARE |
AMPH | $22.01 | COMPARE |
BBNX | $19.72 | COMPARE |